Publisher
Springer Science and Business Media LLC
Reference108 articles.
1. Raventos-Suarez C, Long B. A multiparameter approach to cell cycle analysis as a standard tool in oncology drug discovery. In: Litwin V, Marder P, editors. Flow Cytometry in Drug Discovery and Development. Wiley-Blackwell, John Wiley & Sons, Inc.: New Jersey; 2011. p. 99–122.
2. Sarikonda G, Mathieu M, Natalia M, Pahuja A, Xue Q, Pierog PL, et al. Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses. Cytom Part B - Clin Cytom [Internet]. 2021 Jan 1 [cited 2021 Mar 19];100(1):79–91. Available from: https://pubmed.ncbi.nlm.nih.gov/33373096/
3. Sarikonda G, Pahuja A, Kalfoglou C, Burns K, Nguyen K, Ch’en IL, et al. Monitoring CAR-T cell kinetics in clinical trials by multiparametric flow cytometry: benefits and challenges [Internet]. Vol. 100, Cytometry Part B - Clinical Cytometry. John Wiley and Sons Inc; 2021 [cited 2021 Mar 19]. p. 72–8. Available from: https://pubmed.ncbi.nlm.nih.gov/32573972/
4. Stewart JJ, Green CL, Jones N, Liang M, Xu Y, Wilkins DEC, et al. Role of receptor occupancy assays by flow cytometry in drug development [Internet]. Vol. 90, Cytometry. Part B, Clinical cytometry. Cytometry B Clin Cytom; 2016 [cited 2021 Mar 19]. p. 110–6. Available from: https://pubmed.ncbi.nlm.nih.gov/26704557/
5. Green CL, Stewart JJ, Högerkorp CM, Lackey A, Jones N, Liang M, et al. Recommendations for the development and validation of flow cytometry-based receptor occupancy assays [Internet]. Vol. 90, Cytometry. Part B, Clinical cytometry. Cytometry B Clin Cytom; 2016 [cited 2021 Mar 19]. p. 141–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26566147/
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献